| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| TRV-120027 |
NMeGly-Arg-Val-Tyr-Ile-His-Pro-DAla |
1234510-46-3 |
詳細(xì)
|
| H-Ala-Trp-Ala-OH |
H-ALA-TRP-ALA-OH |
126310-63-2 |
詳細(xì)
|
| Dp-Cl-Phe6，Leu17]-VIP |
(P-CHLORO-D-PHE6,LEU17)-VIP (HUMAN, BOVINE, PORCINE, RAT) |
102805-45-8 |
詳細(xì)
|
| D-D-D-D-D |
ASP-ASP-ASP-ASP-ASP |
124219-00-7 |
詳細(xì)
|
| HPV16-E711-20 epitope |
HPV16-E711-20 epitope |
160040-04-0 |
詳細(xì)
|
| CyclotraxinB |
H-CYS-ASN-PRO-MET-GLY-TYR-THR-LYS-GLU-GLY-CYS-OH(DISULFIDE BRIDGE:CYS1-CYS11) |
1203586-72-4 |
詳細(xì)
|
| P60c-src Substrate II |
AC-ILE-TYR-GLY-GLU-PHE-NH2 |
168781-78-0 |
詳細(xì)
|
| MMP-1 Substrate I, fluorogenic |
DNP-PRO-LEU-ALA-LEU-TRP-ALA-ARGDNP-PRO-LEU-GLY-MET-TRP-SER-ARGCYS-THR-THR-HIS-TRP-GLY-PHE-THR-LEU-CYS |
135662-04-3 |
詳細(xì)
|
| D-γ-Glutamyl-D-glutamicacid |
D-γ-Glutamyl-D-glutamic acid |
4553-17-7 |
詳細(xì)
|
| GR 94800 |
BZ-ALA-ALA-D-TRP-PHE-D-PRO-PRO-NLE-NH2 |
141636-65-9 |
詳細(xì)
|
| FSL1 |
FSL-1 lipoprotein, synthetic |
322455-70-9 |
詳細(xì)
|
| Pam2CSK4 |
Pam2CSK4 |
868247-72-7 |
詳細(xì)
|
| α-Bungarotoxin |
Α-金環(huán)蛇毒 |
11032-79-4 |
詳細(xì)
|
| H-Val-Pro-Pro-OH |
H-VAL-PRO-PRO-OH |
58872-39-2 |
詳細(xì)
|
| MSG606 |
BUTANOIC ACID-GLY-HIS-D-PHE-ARG-D-TRP-CYS-ASP-ARG-PHE-GLY-NH2(CARBA SULFIDE BRIDGE:BUA1-CYS7) |
1416983-77-1 |
詳細(xì)
|
| ALX40-4C |
ALX 40-4C |
143413-49-4 |
詳細(xì)
|
| Rac1InhibitorW56 |
RAC1 INHIBITOR W56 |
1095179-01-3 |
詳細(xì)
|
| Gly6 |
H-GLY-GLY-GLY-GLY-GLY-GLY-OH |
3887-13-6 |
詳細(xì)
|
| TC14012 |
TC 14012 |
368874-34-4 |
詳細(xì)
|
| H-Ala-Ala-Tyr-OH |
H-ALA-ALA-TYR-OH |
67131-52-6 |
詳細(xì)
|
| BimBH3,PeptideIV |
Bim BH3, Peptide IV |
721885-31-0 |
詳細(xì)
|
| Competence-StimulatingPeptide-12261 |
Competence-Stimulating Peptide-12261 |
1235882-91-3 |
詳細(xì)
|
| Tetraglycine |
四聚甘胺酸 |
637-84-3 |
詳細(xì)
|
| (D)-PPA1 |
H-D-ASN-D-TYR-D-SER-D-LYS-D-PRO-D-THR-D-ASP-D-ARG-D-GLN-D-TYR-D-HIS-D-PHE-OH |
1620813-53-7 |
詳細(xì)
|
| AtPep3 |
H-GLU-ILE-LYS-ALA-ARG-GLY-LYS-ASN-LYS-THR-LYS-PRO-THR-PRO-SER-SER-GLY-LYS-GLY-GLY-LYS-HIS-ASN-OH |
902781-14-0 |
詳細(xì)
|
| Rapastinel |
雷帕替奈 |
117928-94-6 |
詳細(xì)
|
| CDK2 |
255064-79-0 |
255064-79-0 |
詳細(xì)
|
| Myomodulin |
MYOMODULIN A TRIFLUOROACETATE SALT |
110570-93-9 |
詳細(xì)
|
| CyclosporinD |
環(huán)孢霉素D |
63775-96-2 |
詳細(xì)
|
| SV40 T-Ag-derived NLS peptide |
PRO-LYS-LYS-LYS-ARG-LYS-VAL-GLU-ASP-*PRO-TYR-CYS |
105425-98-7 |
詳細(xì)
|
| CysHHC10 |
CYSHHC10 |
1408311-03-4 |
詳細(xì)
|
| Nemifitide di |
NETAMIFTIDE |
204992-09-6 |
詳細(xì)
|
| CyclosporinA-Derivative1 |
1487360-85-9 |
1487360-85-9 |
詳細(xì)
|
| Fz7-21 |
Fz7-21 |
2247635-23-8 |
詳細(xì)
|
| TAT-GluA23Y |
H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-TYR-LYS-GLU-GLY-TYR-ASN-VAL-TYR-GLY-OH |
1404188-93-7 |
詳細(xì)
|
| RS 09 |
H-ALA-PRO-PRO-HIS-ALA-LEU-SER-OH |
1449566-36-2 |
詳細(xì)
|
| JAG-1,scrambled |
JAG-1, scrambled |
402941-23-5 |
詳細(xì)
|
| PG931 |
AC-NLE-ASP-PRO-D-PHE-ARG-TRP-LYS-PRO-VAL-NH2 |
667430-81-1 |
詳細(xì)
|
| H-Cys-Gly-Gly-Arg-Gly-Asp-OH |
|
1260223-44-6 |
詳細(xì)
|
| A-71915TFA |
A 71915 |
132956-87-7 |
詳細(xì)
|
| AUNP-12 |
調(diào)節(jié)劑多肽 |
1353563-85-5 |
詳細(xì)
|
| Catestatin |
酪蛋白肽 |
142211-96-9 |
詳細(xì)
|
| N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu |
AC-TYR(PO3H2)-GLU-GLU-ILE-GLU-OH |
159439-02-8 |
詳細(xì)
|
| ELA-21(human) |
H-LEU-ARG-LYS-HIS-ASN-CYS-LEU-GLN-ARG-ARG-CYS-MET-PRO-LEU-HIS-SER-ARG-VAL-PRO-PHE-PRO-OH(DISULFIDE BRIDGE:CYS6-CYS11) |
2245073-05-4 |
詳細(xì)
|
| SIYRY |
SIYRY |
178561-37-0 |
詳細(xì)
|
| Apraglutide |
Apraglutide |
1295353-98-8 |
詳細(xì)
|
| Dynamin inhibitory peptide |
動(dòng)力抑制肽 |
251634-21-6 |
詳細(xì)
|
| Neuronostatin-13 human |
Neuronostatin-13 trifluoroacetate salt |
1096485-24-3 |
詳細(xì)
|
| PKC β pseudosubstrate |
PKC抑制劑多肽 |
172308-76-8 |
詳細(xì)
|
| H-D-Leu-Tyr-OH |
D-亮氨酰-L-酪氨酸水合物 |
3303-29-5 |
詳細(xì)
|
| HAEGTFTSDVS |
HAEGTFTSDVS |
864915-61-7 |
詳細(xì)
|
| CGP 42112 |
CGP 42112;NΑ-NICOTINOYL-TYR-(NΑ-CBZ-ARG)-LYS-HIS-PRO-ILE |
127060-75-7 |
詳細(xì)
|
| ANQ 11125 |
H-PHE-VAL-PHE-ILE-PHE-THR-TYR-GLY-GLU-LEU-GLN-ARG-LEU-GLN-OH |
153966-48-4 |
詳細(xì)
|
| gamma-Glu-leu |
N-L-gamma-谷氨酰-L-亮氨酸 |
2566-39-4 |
詳細(xì)
|
| Phe-Gly-Gly |
L-苯丙氨酰甘氨酰甘氨酸 |
23576-42-3 |
詳細(xì)
|
| GamaGlu-Val-Gly |
GLUTAMYL-VALYL-GLYCINE |
38837-70-6 |
詳細(xì)
|
| Fmoc-Val-Cit-OH |
(S)-2 - ((S)-2 - (((((9H-芴-9-基)甲氧基)羰基)氨基)-3-甲基丁酰氨基 |
159858-21-6 |
詳細(xì)
|
| Difelikefalin Impurities |
H-D-Phe-D-Phe-D-Leu-D-Lys-Pip-OH |
1024828-77-0 |
詳細(xì)
|
| gamma-DGG |
Γ-D-谷氨?；拾彼?/td>
| 6729-55-1 |
詳細(xì)
|
| YAP-TEAD-IN-1 |
YAP-TEAD Inhibitor 1 |
1659305-78-8 |
詳細(xì)
|
| H-Ser-Ser-OH |
H-SER-SER-OH |
6620-95-7 |
詳細(xì)
|
| CART(55-102)(human) |
CART (55-102) (HUMAN) |
214050-22-3 |
詳細(xì)
|
| CTCE-9908 |
(LYS-GLY-VAL-SER-LEU-SER-TYR-ARG)2-LYS-NH2 |
1030384-98-5 |
詳細(xì)
|
| Alarin (Human) |
Alarin (human) |
909409-86-5 |
詳細(xì)
|
| Parstatin (human) |
血管生成抑制劑 |
1065755-99-8 |
詳細(xì)
|
| MC-Val-Cit-PAB |
MC-Val-Cit-PAB |
159857-80-4 |
詳細(xì)
|
| H-Leu-Pro-OH hydrochloride |
H-LEU-PRO-OH · HCL |
87178-63-0 |
詳細(xì)
|
| H-His-Phe-OH |
H-HIS-PHE-OH |
16874-81-0 |
詳細(xì)
|
| OVAG4peptide |
H-SER-ILE-ILE-GLY-PHE-GLU-LYS-LEU-OH |
148274-82-2 |
詳細(xì)
|
| PL017 |
N-Me-phe（3）-嗎啡肽 |
83397-56-2 |
詳細(xì)
|
| p2Ca |
142606-55-1 |
142606-55-1 |
詳細(xì)
|
| N-Acetyl-O-phosphono-Tyr-GluDipentylamide |
AC-TYR(PO3H2)-GLU-DIPENTYLAMIDE |
190078-50-3 |
詳細(xì)
|
| RC-3095 |
NULL |
138147-78-1 |
詳細(xì)
|
| Lei-Dab 7 |
(DAB7)-LEIUROTOXIN I |
1061556-49-7 |
詳細(xì)
|
| C21 |
AC-SER-GLY-N5-(2-CHLORO-1-IMINOETHYL)]-ORN)-GLY-LYS-GLY-GLY-LYS-GLY-LEU-GLY-LYS-GLY-GLY-ALA-LYS-ARG-HIS-ARG-LYS-VAL |
1229236-78-5 |
詳細(xì)
|
| HEX3 |
HEX3 |
688805-40-5 |
詳細(xì)
|
| CyclosporinA-Derivative2 |
環(huán)孢菌素A-衍生物2 |
156047-45-9 |
詳細(xì)
|
| Cyclo(phenylalanylprolyl) |
六氫-3-(苯基甲基)吡咯并[1,2-A]吡嗪-1,4-二酮 |
14705-60-3 |
詳細(xì)
|
| PG106 |
ZFZDDBJAFMOQSH-UHFFFAOYSA-N |
944111-22-2 |
詳細(xì)
|
| Ac-D-Arg-Cys-Glu-His-D-Phe-Arg-Trp-Cys-NH2(Disulfide bridge：Cys2-Cys8) |
ACETYL-(D-ARG10,CYS11,D-PHE14,CYS17)-Β-MSH (10-17) AMIDE TRIFLUOROACETATE SALT |
819048-44-7 |
詳細(xì)
|
| UFP 803 |
H-ASP-PEN-PHE-TRP-DAB-TYR-CYS-VAL-OH(DISULFIDE BRIDGE:PEN2-CYS7) |
879497-82-2 |
詳細(xì)
|
| Urocortin II,mouse |
UROCORTIN II (小鼠) |
330648-32-3 |
詳細(xì)
|
| R18 |
H-PRO-HIS-CYS-VAL-PRO-ARG-ASP-LEU-SER-TRP-LEU-ASP-LEU-GLU-ALA-ASN-MET-CYS-LEU-PRO-OH |
211364-78-2 |
詳細(xì)
|
| Toxic Shock SyndroMe Toxin-1 (TSST-1) (58-78） |
TOXIC SHOCK SYNDROME TOXIN-1 (TSST-1) (58-78) |
137593-46-5 |
詳細(xì)
|
| P60c-src Substrate II, Phosphorylated |
AC-ILE-TYR(PO3H2)-GLY-GLU-PHE-NH2 |
284660-72-6 |
詳細(xì)
|
| Prepro VIP (111-122) (human) |
preprovasoactive intestinal peptide (111-122) |
123025-94-5 |
詳細(xì)
|
| D-Phe2]-VIP (human, bovine, porcine, rat) |
(D-PHE2)-VIP (HUMAN, BOVINE, PORCINE, RAT) |
104051-15-2 |
詳細(xì)
|
| JMV 449 |
JMV 449 |
139026-66-7 |
詳細(xì)
|
| Huwentoxin XVI |
H-CYS-ILE-GLY-GLU-GLY-VAL-PRO-CYS-ASP-GLU-ASN-ASP-PRO-ARG-CYS-CYS-SER-GLY-LEU-VAL-CYS-LEU-LYS-PRO-THR-LEU-HIS-GLY-ILE-TRP-TYR-LYS-SER-TYR-TYR-CYS-TYR-LYS-LYS-OH(DISULFIDE BRIDGE:CYS1-CYS16;CYS8-CYS21;CYS15-CYS36) |
1600543-88-1 |
詳細(xì)
|
| Pressinoic Acid |
PRESSINOIC ACID |
35748-51-7 |
詳細(xì)
|
| LAH4 |
H-LYS-LYS-ALA-LEU-LEU-ALA-LEU-ALA-LEU-HIS-HIS-LEU-ALA-HIS-LEU-ALA-LEU-HIS-LEU-ALA-LEU-ALA-LEU-LYS-LYS-ALA-OH |
184776-51-0 |
詳細(xì)
|
| c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm |
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm |
1647119-71-8 |
詳細(xì)
|
| WKYMVM |
H-TRP-LYS-TYR-MET-VAL-D-MET-NH2 |
187986-17-0 |
詳細(xì)
|
| Cotadutide acetate |
COTADUTIDE ACETATE |
1686108-82-6 |
詳細(xì)
|
| p5 Ligand for Dnak and DnaJ |
P5 LIGAND FOR DNAK AND DNAJ |
209518-24-1 |
詳細(xì)
|
| Hsp70-derivedoctapeptide |
HSP70-DERIVED OCTAPEPTIDE |
736171-62-3 |
詳細(xì)
|
| H-His-Pro-OH |
H-HIS-PRO-OH |
20930-58-9 |
詳細(xì)
|
| Rac1 Inhibitor F56, control peptide |
H-MET-VAL-ASP-GLY-LYS-PRO-VAL-ASN-LEU-GLY-LEU-PHE-ASP-THR-ALA-GLY-OH |
1315378-77-8 |
詳細(xì)
|
| Tyroserleutide hydrochloride |
Tyr-Ser-Leu |
852982-42-4 |
詳細(xì)
|
| Oligopeptide P11-4 |
Oligopeptide P11-4 |
593266-60-5 |
詳細(xì)
|